WO2024218571 - METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING EOSINOPHILIC ESOPHAGITIS
National phase entry:
Publication Number
WO/2024/218571
Publication Date
24.10.2024
International Application No.
PCT/IB2024/000197
International Filing Date
18.04.2024
Title **
[English]
METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING EOSINOPHILIC ESOPHAGITIS
[French]
MÉTHODES ET COMPOSITIONS POUR PRÉVENIR OU TRAITER L'OESOPHAGITE À ÉOSINOPHILES
Applicants **
REVOLO BIOTHERAPEUTICS LIMITED
Windsor House
Station Court, Station Road
Great Shelford, Cambridgeshire CB22 5NE, GB
Inventors
FOULKES, Roly
Flat B
26, Spittal Street
Marlow SL7 1DB, GB
DE ALBA, Jorge
85 Hertford Road
Stevenage, Hertfordshire SG2 8SE, GB
Priority Data
63/496,921
18.04.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1499 | |
| EPO | Filing, Examination | 7520 | |
| Japan | Filing | 597 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 3110 |
Total: 13301 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
Described herein are methods for preventing or treating eosinophilic esophagitis (EoE) by administrating peptides related to Chaperonin 60.1 to subjects afflicted with EoE.[French]
L'invention concerne des méthodes de prévention ou de traitement de l'oesophagite à éosinophiles (EoE) par administration de peptides associés à la chaperonine 60.1 à des sujets atteints d'EoE.